Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity
Johan Courjon, Océane Dufies, Alexandre Robert, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1523-1534
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway
Bariaa Khalil, Narjes Saheb Sharif‐Askari, Shirin Hafezi, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0302818-e0302818
Open Access | Times Cited: 1
NLRP3 expression and its predictive role in preserved ejection fraction among non-valvular atrial fibrillation patients
Shijian Chen, Ziheng Yu, Wen Wen, et al.
Cardiology (2024), pp. 1-7
Closed Access | Times Cited: 1
The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons
Luz E. Cabrera, Suvi T. Jokiranta, Sanna Mäki, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012368-e1012368
Open Access | Times Cited: 1
Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin
Kate Chander Chiang, Ajay Gupta, Prithu Sundd, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 338-338
Open Access | Times Cited: 4
Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients
Barbara Adamik, Magdalena Ambrożek-Latecka, Barbara Dragan, et al.
Shock (2022) Vol. 57, Iss. 5, pp. 672-679
Open Access | Times Cited: 6
Alcohol use disorder as a potential risk factor forCOVID‐19 severity: A narrative review
Christopher B. Forsyth, Robin M. Voigt, Garth Swanson, et al.
Alcoholism Clinical and Experimental Research (2022) Vol. 46, Iss. 11, pp. 1930-1943
Open Access | Times Cited: 6
Platelet caspase‐1 and Bruton tyrosine kinase activation in patients with COVID‐19 is associated with disease severity and reversed in vitro by ibrutinib
Livia Claude, Frédéric Martino, Patricia Hermand, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 8, pp. e12811-e12811
Open Access | Times Cited: 5
The assembly of neutrophil inflammasomes during COVID-19 is mediated by type I interferons
Luz E. Cabrera, Suvi T. Jokiranta, Sanna Mäki, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Pyroptosis targeting via mitochondria: An educated guess to innovate COVID‐19 therapies
Aarti Singh, Daniela Strobbe, Michelangelo Campanella
British Journal of Pharmacology (2021) Vol. 179, Iss. 10, pp. 2081-2085
Open Access | Times Cited: 6
L’inflammasome NLRP3 dans la physiopathologie des infections virales
Marlène Chemarin, Océane Dufies, Anastassia Mazet, et al.
médecine/sciences (2022) Vol. 38, Iss. 6-7, pp. 545-552
Open Access | Times Cited: 4
Monitoring NLRP3 Inflammasome Activation and Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC Speck Formation Measurement Directly in Whole Blood after Ex Vivo Stimulation
Rémy Coudereau, Morgane Gossez, Bénédicte F. Py, et al.
Cells (2022) Vol. 11, Iss. 20, pp. 3306-3306
Open Access | Times Cited: 4
Casual relationship between 731 immunophenotypes and sepsis: A Bidirectional Two-sample mendelian randomization study
Daishan Jiang, Tingting Bian, Yan Shen, et al.
Research Square (Research Square) (2024)
Open Access
IL-1b drives SARS-CoV-2 disease in vivo, independently of the inflammasome and pyroptotic signalling
Marcel Doerflinger, Stefanie M. Bader, L.R. Scherer, et al.
Research Square (Research Square) (2024)
Open Access
NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection
Consolato Sergi
Vaccines (2022) Vol. 10, Iss. 8, pp. 1307-1307
Open Access | Times Cited: 3
Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients
Rémy Coudereau, Guillaume Monneret, Anne‐Claire Lukaszewicz, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2419-2419
Open Access | Times Cited: 1
Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity
Julio García-Villalba, Laura Hurtado‐Navarro, Alejandro Peñín‐Franch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 1
NLRP3 inflammasome activation and its inhibitory drugs in connection with COVID-19 infection
Khashayar Zafar-Mohammadi, Javad Poursamimi, Mahdi Atabaki
European Journal of Inflammation (2022) Vol. 20
Open Access | Times Cited: 1
Inflammasome-related markers at the ICU admission are not associated with outcome in the critically ill COVID-19 patients
Barbara Adamik, Magdalena Ambrożek-Latecka, Barbara Dragan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Uncovering the Neutrophil Inflammatory Response in Severe COVID-19: Implications of Type I Interferon in Inflammasome Activation
Luz Eneida Cabrera Lara, Suvi T. Jokiranta, Sanna Mäki, et al.
(2023)
Closed Access
Safety and Efficacy of Disulfiram in Hospitalized Patients with Moderate COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial.
Augusto César de Andrade Mota, Valdir C. Sant’Ana Filho, Carolyn M. Hendrickson, et al.
(2023)
Closed Access
SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1αin pulmonary epithelial and endothelial cells
Magdalena Ambrożek-Latecka, Piotr Kozłowski, Grażyna Hoser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top